Abstract
Aim - studying of quality of life of the patients with multiple sclerosis receiving the medicines changing the course of multiple sclerosis, the first and second line for identification of the most optimum methods of therapy of a disease. Materials and methods. Survey of 100 patients aged from 18 up to 65 years receiving medicines of the first and second line by means of a scale of hospital alarm and a depression of HADS and the questionnaire of quality of life of SF-36 is conducted. Results. The obtained data have shown that medicines of the second line authentically raise physical and social indicators of quality of life; in addition, the interrelation between an emotional condition of the patient and degree of his social activity is found. Conclusion. It is established that the alarm and a depression significantly limit physical activity of the patient, reduce independent assessment by the patient of a condition of the health and quality of life of patients. It is necessary to estimate the level of alarm and a depression at patients with multiple sclerosis and to correct the phenomena of emotional instability as they influence physical health, social contacts, level of pain and, as a result, quality of life.
Highlights
Цель – изучение качества жизни пациентов с рассеянным склерозом, которые получают препараты, изменяющие течение рассеянного склероза первой и второй линии, для выявления наиболее оптимальных методов терапии заболевания
The obtained data have shown that medicines of the second line authentically raise physical and social indicators of quality of life; in addition, the interrelation between an emotional condition of the patient and degree of his social activity is found
It is established that the alarm and a depression significantly limit physical activity of the patient, reduce independent assessment by the patient of a condition of the health and quality of life of patients
Summary
Цель – изучение качества жизни пациентов с рассеянным склерозом, которые получают препараты, изменяющие течение рассеянного склероза первой и второй линии, для выявления наиболее оптимальных методов терапии заболевания. Проведен опрос 100 пациентов в возрасте от 18 до 65 лет, получающих препараты первой и второй линии, с помощью шкалы госпитальной тревоги и депрессии HADS и анкеты качества жизни SF-36. Что тревога и депрессия существенно ограничивают физическую активность пациента, снижают самостоятельную оценку пациентом состояния своего здоровья и качество жизни больных.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
